Skip to main content
Show full summary

Lord Framlingham to ask Her Majesty's Government, given the speed with which vaccines against COVID-19 were approved, what are the causes of the delay to the approval of the use of Ivermectin; and what assessment they have made of (1) the approval of Ivermectin by other countries, and (2) the health benefits that would result from approving Ivermectin for use in the UK.  HL6862

Question HL6862: tabled on 10 March 2022 and due for answer by 24 March 2022

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Framlingham to ask Her Majesty's Government, given the speed with which vaccines against COVID-19 were approved, what are the causes of the delay to the approval of the use of Ivermectin; and what assessment they have made of (1) the approval of Ivermectin by other countries, and (2) the health benefits that would result from approving Ivermectin for use in the UK.  HL6862
Legend for business item text
Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.